Skip to main content
    C

    Calidi Biotherapeutics Inc. (CLDI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $0.60
    -0.02 (-2.93%)

    Market Cap: $2.29M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Calidi Biotherapeutics Inc. (CLDI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Calidi Biotherapeutics are PharmaCyte Biotech (PMCB), Ernexa Therapeutics (ERNA) and Bioatla (BCAB). By market cap, Calidi Biotherapeutics ranks 9th of the 13 companies on this page; Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest at $4.02M.

    Peer Comparison

    CLDI's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Calidi Biotherapeutics (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    PharmaCyte Biotech Inc (PMCB)$3.77MN/AN/A0.0%N/A0.0%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    Bioatla Inc (BCAB)$2.89MN/AN/A0.0%N/A31.6%0.00%
    Revelation Biosciences Inc (REVB)$2.43MN/AN/A0.0%N/A0.0%0.00%
    HCW Biologics Inc (HCWB)$1.73MN/A0.2x-83.1%-51.6%1970.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Purple Biotech (PPBT)$2.65MN/AN/A0.0%-156.2%0.0%0.00%
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)$4.02MN/AN/A0.0%-247.2%0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Enlivex Therapeutics Ltd (ENLV)$1.82MN/AN/A0.0%-0.3%0.0%0.00%
    GRI Bio Inc. (GRI)$3.72MN/AN/A0.0%N/A0.0%0.00%
    Scinai Immunotherapeutics Ltd (SCNI)$1.05MN/AN/A-80.1%N/A572.0%0.00%
    Peer median$2.75MN/A0.9x0.0%-103.9%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Calidi Biotherapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    PharmaCyte Biotech Inc (PMCB)
    PharmaCyte Biotech, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cell therapies for cancer and diabetes in the United...
    PMCB competitors
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    Bioatla Inc (BCAB)
    BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers.
    BCAB competitors
    Revelation Biosciences Inc (REVB)
    Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics...
    REVB competitors
    HCW Biologics Inc (HCWB)
    HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues...
    HCWB competitors
    Curis Inc (CRIS)
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors
    Purple Biotech (PPBT)
    Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United...
    PPBT competitors
    Liminatus Pharma, Inc. Class A Common Stock (LIMN)
    Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
    LIMN competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Enlivex Therapeutics Ltd (ENLV)
    Enlivex Therapeutics Ltd. is a clinical stage immunotherapy company. The company is headquartered in Nes Ziona, Israel.
    ENLV competitors
    GRI Bio Inc. (GRI)
    GRI Bio Inc. is an innovative biotechnology company focused on leveraging microbiome technology to develop cutting-edge therapeutics in immunology and oncology.
    GRI competitors
    Scinai Immunotherapeutics Ltd (SCNI)
    Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune...
    SCNI competitors

    Frequently Asked Questions About CLDI

    Who are Calidi Biotherapeutics' main competitors?

    The companies most similar to Calidi Biotherapeutics include PharmaCyte Biotech (PMCB), Ernexa Therapeutics (ERNA), Bioatla (BCAB), Revelation Biosciences (REVB) and HCW Biologics (HCWB), listed from the closest match.

    Who is Calidi Biotherapeutics' biggest competitor?

    Liminatus Pharma, Inc. Class A Common Stock (LIMN) is the largest of the similar companies at $4.02M; PharmaCyte Biotech (PMCB) is the closest match by business profile, size, sector and industry.

    How does CLDI stock compare with its competitors?

    CLDI's net margin is 0.0% against a peer median of 0.0%.

    Which of Calidi Biotherapeutics' competitors pays a higher dividend?

    Calidi Biotherapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Calidi Biotherapeutics bigger than its competitors?

    No. Calidi Biotherapeutics is 9th by market cap among the 13 companies on this page; the largest is Liminatus Pharma, Inc. Class A Common Stock (LIMN) at $4.02M.